Objective: It has been reported that women receive fewer preventive recommendations regarding pharmacological treatment, lifestyle modifications, and cardiac rehabilitation compared with men who have a similar risk profile. This study was an investigation of the impact of gender on cardiovascular risk profile and secondary prevention measures for coronary artery disease (CAD) in the Turkish population. Methods: Statistical analyses were based on the European Action on Secondary and Primary Prevention through Intervention to Reduce Events (EUROASPIRE)-IV cross-sectional survey data obtained from 17 centers in Turkey. Male and female patients, aged 18 to 80 years, who were hospitalized for a first or recurrent coronary event (coronary artery bypass graft, percutaneous coronary intervention, acute myocardial infarction, or acute myocardial ischemia) were eligible. Results: A total of 88 (19.7%) females and 358 males (80.3%) were included. At the time of the index event, the females were significantly older (p=0.003) and had received less formal education (p<0.001). Non-smoking status (p<0.001) and higher levels of depression and anxiety (both p<0.001) were more common in the female patients. At the time of the interview, conducted between 6 and 36 months after the index event, central obesity (p<0.001) and obesity (p=0.004) were significantly more common in females. LDL-C, HDL-C or HbA1c levels did not differ significantly between genders. The fasting blood glucose level was significantly higher (p=0.003) and hypertension was more common in females (p=0.001). There was no significant difference in an increase in physical activity or weight loss after the index event between genders, and there was no significant difference between genders regarding continuity of antiplatelet, statin, beta blocker or ACEi/ARB II receptor blocker usage (p>0.05). Conclusion: Achievement of ideal body weight, fasting blood glucose and blood pressure targets was lower in women despite similar reported medication use. This highlights the importance of the implementation of lifestyle measures and adherence to medications in women.
A wareness of the importance of coronary artery disease (CAD) as a cause of mortality in women has increased in the last decade. [1] Its impact on women's health had previously been underappreciated due to the higher incidence of CAD at younger ages in men. However, it is now known that CAD mortality is higher in women than in men. [2] Several papers have suggested that gender-based differences exist regarding secondary prevention of CAD. Unfortunately, women are known to receive fewer preventive recommendations regarding both lifestyle modifications and pharmacological treatment compared with men who have a similar risk profile. [3] [4] [5] [6] [7] Furthermore, cardiac rehabilitation after myocardial infarction (MI) has been reported to be underused in women. [8] [9] [10] [11] The recently published Türk Erişkinlerinde Kalp Hastalığı ve Risk Faktörleri (TEKHARF) survey revealed a higher CAD mortality in men (5.7/1000 vs. 3.6/1000 individuals per year), but a higher incidence of CAD in women between 1998 and 2014 (16.2/1000 vs. 15.2/ 1000 individuals per year). [12] Despite a lower CAD mortality compared with Turkish men, CAD mortality in Turkish women is known to be the highest among European countries. [13, 14] These data suggest the emergent need for the implementation of prevention measures for CAD in women.
The aim of this study was to investigate the impact of gender on determinants of secondary prevention measures in the Turkish population.
METHODS
Analyses were based on the European Action on Secondary and Primary Prevention through Intervention to Reduce Events (EUROASPIRE, EA)-IV crosssectional survey (2012-2013) data obtained from 17 centers in Turkey. [15] Males and females aged 18 to 80 years who were hospitalized for a first or recurrent coronary event (coronary artery bypass grafting [CABG] , percutaneous coronary intervention [PCI] , acute MI [AMI], or acute myocardial ischemia) were eligible for inclusion in the survey. Data collection was performed by trained research staff. Written informed consent was obtained from each participant.
Information on personal and demographic details, co-morbidities, medications, smoking status, and anthropometric measurements were obtained from medical records. The patients were examined and interviewed (selfreported information on lifestyle, other risk factor management, and medication) between 6 months and 3 years after the recruiting diagnosis.
Being overweight or obese was defined as having a body mass index (BMI) ≥25 kg/m 2 or ≥30 kg/m 2 , respectively. Central obesity was defined as a waist circumference ≥102 cm in males and ≥88 cm in females. A high-density lipoprotein-cholesterol (HDL-C) level not on target was defined as <40 mg/dL in male and <45 mg/dL in females. Low-density lipoprotein-cholesterol (LDL-C) that was not on target was defined as a level of ≥70 mg/dL. Diabetes was defined as a fasting blood glucose value of ≥126 mg/dL. Hypertension was defined as a systolic blood pressure measurement of ≥140 (≥130 in diabetic patients) and/or diastolic blood pressure ≥90 (≥80 in diabetic patients) mm Hg. In addition, the EUROASPIRE-III (EA-III) data were used to compare the prevalence of cardiovascular risk factors in the Turkish population with that identified in the EA-IV. The EA-III survey was carried out between 2006 and 2007, and the data were obtained from the same 17 centers in Turkey. The diagnostic criteria for inclusion were similar to those of the EA-IV.
Statistical analysis
The data were analyzed using PASW Statistics for Windows, Version 18.0 (SPSS Inc., Chicago, IL, USA). Descriptive statistics were expressed as numbers and percentages for categorical variables and as mean ± standard deviation or median (percentile 25 [Q1]-percentile 75 [Q3]) for numerical variables. The numerical variables were investigated using the Kolmogorov-Smirnov test to determine if there was normal distribution. For categorical variables, a chi-square test was used in 2 groups and multiple comparisons when the chi-square condition was met. Continuity correction and Fisher's exact tests were used for multiple comparisons when the chi-square Comparison of males and females regarding their cardiovascular risk profile at the time of the interview undertaken 6 to 36 months following the index event is shown in Table 2 . Central obesity (85.3 vs. 41.8%; p<0.001) and obesity (62.9 vs. 36.8%; p=0.007) were significantly more common in females compared with males. LDL-C, HDL-C or HbA1c levels did not differ between males and females (all p>0.05). However, more females were found to have a higher fasting blood glucose level (51.6 vs. 25.5%, p=0.006). Hypertension was also more common in females (69.4 vs. 40.6%; p=0.002), whereas smoking, defined as self-reported smoking at the time of interview or carbon monoxide in the breath >10 ppm, was more common in males (28.7 vs. 8.1%; p=0.015). An increase in physical activity or weight loss after the index event did not differ between genders (all p>0.05). In addition, continuation of medical treatment with antiplatelets, statins, beta blockers or angiotensinconverting enzyme (ACE) inhibitors/angiotensin II receptor blockers was similar (p>0.05).
ence concerning the type of index event (CABG, PCI, AMI, ischemia) between male and female patients (p=0.681). Table 1 illustrates the comparison of males and females in terms of their cardiovascular risk profile at the time of the index event. At the time of index event, females were significantly older than males (p=0.003). When age groups (<50, 50-59, 60-69, ≥70 years) were compared, the ratio of males who experienced the index event at an age younger than 50 was significantly higher than that of females (21. A total of 669 patients (510 men and 159 women) were included in the EA-III and 338 patients (50.5%) were interviewed at least 6 months after the index event. A comparison of EA-IV and EA-III data regarding the cardiovascular risk profile in females at the time of index event is shown in Table 3 . At the time of the index event, LDL-C, HDL-C, BMI, fasting blood glucose, smoking status and blood pressure values were similar in females participating in the EA-III and EA-IV (all p>0.05). Females in the EA-III were older than those included in the EA-IV (p=0.024) ( Table 3 ). The presence of 3 or more cardiovascular risk factors was not found to be significantly associated with gender neither at the time of the index event (47.1 vs. 43.8; p=0.574) or interview (78.4 vs. 62.9%; p=0.069) among EA-IV participants, although it was numerically greater in females. However, among the EA-III participants, more females were found to have 3 or more cardiovascular risk factors at the time of the interview (81.5 vs. 56%; p<0.001), but not at that of the index event (26.7 vs. 27.2%; p=0.894).
Comparison of target achievement in males and females among participants of the EA-IV is shown in Table 4 . The percentage of females who reached their blood pressure target was significantly lower than that of males (22.2 vs. 53.4%; p=0.031). Target achievement for other cardiovascular risk factors did not differ between genders (all p>0.05). Changes in LDL-C, HDL-C, HbA1c or fasting blood glucose levels did not differ with respect to education level (having completed more than primary school vs. primary school or less) or age at the index event (<65 vs. ≥65 years) in females (all p>0.05). Target achievement concerning unfortunately being undereducated at the time of the index event, the clinical cardiovascular risk profile in females was similar to that of males at the time of the index event. However, despite the similarity at the time of the index event, a difference in the prevalence of central obesity, obesity, higher fasting blood glucose levels and hypertension that favored males was observed at follow-up. Target achievement in females regarding obesity, fasting blood glucose levels, and blood pressure was significantly insufficient at the time of the follow-up interview. Regrettably, despite the 6-year interval between the EA-III and EA-IV surveys, neither the education status, nor the clinical cardiovascular risk profile seemed to improve in females.
Coronary artery disease results in more adverse events in women than in men. Among individuals 45 to 64 years of age, women have been found to be more likely to suffer from heart failure following MI [2] and anginal episodes. [2, 16] Cardiovascular risk factor mod-BMI, LDL-C, HDL-C, HbA1c, fasting blood glucose or blood pressure in females also did not significantly differ according to education level (having completed more than primary school vs. primary school or less) or age at the index event (<65 vs. ≥65 years) in females (all p>0.05). In addition, target achievement in cardiovascular risk factors among females was not influenced by neither age or educational status at the time of the index event (all p>0.05). Changes in LDL-C, HDL-C, HbA1c, or fasting blood glucose levels that were observed at follow-up in females were also not associated with age or educational status at the time of the index event (all p>0.05).
DISCUSSION
The EUROASPIRE-IV Turkish arm data revealed a large gap between males and females regarding secondary prevention measures. Our findings indicate that except for smoking less and being older, and [17] Older age at the time of the index event may be a limiting factor in target achievement in secondary prevention. Less education in women may also lead to lower awareness. [18] Although age and education status were significantly associated with having 3 or more cardiovascular risk factors in the European survey, [17] our results did not demonstrate such a relationship. This may be due to the relatively small number of women included in the survey in the Turkish arm of the EA-IV.
Compliance with lifestyle advice and adherence to physical activity advice or weight change recommendations did not differ significantly between genders in the Turkish population, which was similar to what was observed in other European countries. [17] However, females were still found to be more obese at the time of the interview, despite the lack of a significant difference regarding weight loss or attempt for physical activity between genders. Social barriers existing in many countries may restrict women from the adoption of healthy lifestyle habits. In addition, women are known to be less likely to maintain a healthy lifestyle status due to household and caretaking responsibilities or comorbidities (such as osteoarthritis, osteoporosis), particularly in the postmenopausal period. Lack of access to healthy food and fitness facilities and living in a dangerous neighborhood that restricts outdoor physical activity are among the factors that may limit the improvement of cardiovascular risk factors, particularly in low-income women. Furthermore, women are known to be less successful in coping with depression, anger, stress or boredom compared with males. The higher anxiety and depression levels that we detected in Turkish females may have contributed to the failure in target achievement and cardiovascular risk factor reduction.
Previous studies have suggested that women are prescribed fewer medications for secondary prevention than men. African American or Hispanic women, especially if older, are less likely than white men to receive aspirin, beta blocker, ACE inhibitor or lipid-lowering drugs after MI, despite evidence of benefit. [19, 20] These patients are also less likely to be referred for revascularization procedures [21, 22] and cardiac rehabilitation. [8] [9] [10] [11] The Canadian Acute Coronary Syndrome Registry, which assessed factors influencing the underutilization of evidence-based therapies in women, [23] has shown lower rates of ACE inhibitor, beta blocker, ification after the index event is essential to reduce the associated morbidity and mortality. The EA-IV cross-sectional survey data obtained from 24 European countries has demonstrated a significantly worse risk factor profile in females compared with males, reflected in a higher prevalence of having 3 or more cardiovascular risk factors across all age groups at the time of the index event. [17] At the time of the interview, the prevalence of 3 or more cardiovascular risk factors was numerically greater in the Turkish women included in the EA-IV compared with the men. This finding had reached statistical significance in the EA-III. The failure to reach statistical significance in the current EA-IV survey may be explained by the fact that the number of female participants was relatively smaller in the EA-IV compared with the EA-III.
The findings of the EA-IV Turkish survey indicate that although similar at the time of the index event in terms of having 3 or more cardiovascular risk factors, a difference in the prevalence of central obesity and obesity, higher fasting blood glucose levels and hypertension between genders that favored males was apparent at the follow-up. This may be due to several factors, including older age at diagnosis, lower education status and psychosocial factors (reflected in higher anxiety and depression scores). Along with the global problems in women's health, such as low compliance with lifestyle advice, failure to maintain lifestyle modifications and underutilization of evidence-based medical and interventional therapies, these factors may lead to the gender gap in secondary prevention.
Turkish women were more likely to be non-smokers, both at the time of the index event and the interview, as in other European countries. Obesity and LDL-C, fasting blood glucose and HbA1c values that were not on target were more common in women in Turkey, similar to the findings in other European countries. [17] Although no significant difference in terms of reaching the target blood pressure was observed in other European countries, [17] Turkish women were more likely to have higher blood pressure values compared with males at the time of the interview.
The EUROASPIRE-IV cross-sectional survey data obtained from 24 European countries revealed that females had a significantly lower education level and were older at the time of the index event compared with males, which is consistent with our findings. ment of Cardiology, Hacettepe University Faculty ofand lipid-lowering drug use among women, which correlated with older age. Despite adjustment for biasing confounders, female gender remained associated with underutilization of guideline-based therapy with lipid-lowering drugs and ACE inhibitors. In our study, the reported medication use did not significantly differ between genders in the Turkish population, which was consistent with other European countries. [17] Previous studies have shown that women are less likely to adhere to medications. [24] Our findings do not necessarily reflect compliance with medications.
Limitations
The limited number of women in the study population resulted in failure to reach statistical significance in several statistical analyses. Second, the survey was undertaken in patients from only 3 metropolitan cities. Finally, although a standardized and detailed survey was conducted, data related to physical activity and dietary habits of the patients were based only on patients' own statements.
Conclusion
Our findings demonstrated that secondary prevention measure implementation is insufficient in females compared with males in Turkey, particularly when achievement of ideal body weight and fasting blood glucose and blood pressure targets are concerned. The lack of a significant difference regarding the use of prescribed drugs between genders draws attention to the importance of adherence to healthy lifestyle habits and the efficient use of cardiac rehabilitation to improve outcomes in females. Older age at the time of the index event and psychosocial stress may pose a problem in the adoption of healthy lifestyle habits in females. Therefore, promotion of healthy life habits should be initiated early in childhood.
